Morningside Venture Investments Ltd Apellis Pharmaceuticals, Inc. (APLS) insider trading activity
Morningside Venture Investments LTD is > 10% Shareholder of Apellis Pharmaceuticals, Inc.. Currently has a direct ownership of 12.8 Million shares of APLS, which is worth approximately $425 Million. The most recent transaction as insider was on Nov 18, 2021, when has been sold 250,000 shares (Common Stock) at a price of $40.0 per share, resulting in proceeds of $10,000,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
12.8M
0%
3M change
0%
12M change
Total Value Held
$425 Million
Morningside Venture Investments Ltd Transaction History
Also insider at
MVI
Morningside Venture Investments LTD
> 10% Shareholder
Monaco, O9